Digestive and Liver Disease
Volume 43, Issue 1 , Pages 78-84 , January 2011

Transjugular intrahepatic portosystemic shunt with expanded-polytetrafuoroethylene-covered stents in non-cirrhotic patients with portal cavernoma

  • Fabrizio Fanelli

      Affiliations

    • Dipartimento di Scienze Radiologiche, “Sapienza” Università di Roma, Rome, Italy
    • ,
  • Stefania Angeloni

      Affiliations

    • II Gastroenterologia, Dipartimento di Medicina Clinica, “Sapienza” Università di Roma, Rome, Italy
    • ,
  • Filippo Maria Salvatori

      Affiliations

    • Dipartimento di Scienze Radiologiche, “Sapienza” Università di Roma, Rome, Italy
    • ,
  • Chiara Marzano

      Affiliations

    • II Gastroenterologia, Dipartimento di Medicina Clinica, “Sapienza” Università di Roma, Rome, Italy
    • ,
  • Emanuele Boatta

      Affiliations

    • Dipartimento di Scienze Radiologiche, “Sapienza” Università di Roma, Rome, Italy
    • ,
  • Manuela Merli

      Affiliations

    • II Gastroenterologia, Dipartimento di Medicina Clinica, “Sapienza” Università di Roma, Rome, Italy
    • ,
  • Plinio Rossi

      Affiliations

    • Dipartimento di Scienze Radiologiche, “Sapienza” Università di Roma, Rome, Italy
    • ,
  • Adolfo Francesco Attili

      Affiliations

    • II Gastroenterologia, Dipartimento di Medicina Clinica, “Sapienza” Università di Roma, Rome, Italy
    • ,
  • Lorenzo Ridola

      Affiliations

    • II Gastroenterologia, Dipartimento di Medicina Clinica, “Sapienza” Università di Roma, Rome, Italy
    • ,
  • Federica Cerini

      Affiliations

    • II Gastroenterologia, Dipartimento di Medicina Clinica, “Sapienza” Università di Roma, Rome, Italy
    • ,
  • Oliviero Riggio

      Affiliations

    • II Gastroenterologia, Dipartimento di Medicina Clinica, “Sapienza” Università di Roma, Rome, Italy
    • Corresponding Author InformationCorresponding author at: II Gastroenterologia, Dipartimento di Medicina Clinica, “Sapienza” Università di Roma, Viale dell’Università 37, 00185 Rome, Italy. Tel.: +39 0649972001; fax: +39 0649972001/4453319.

Received 1 March 2010 ,Accepted 2 June 2010.

References 

  1. Primignani M, Martinelli I, Bucciarelli P, et al. Risk factors for thrombophilia in extrahepatic portal vein obstruction. Hepatology. 2005;41:603–608
  2. Valla DC. Thrombosis and anticoagulation in liver disease. Hepatology. 2008;47:1384–1393
  3. Denninger MH, Chait Y, Casadevall N, et al. Cause of portal and hepatic venous thrombosis in adults: the role of multiple concurrent factors. Hepatology. 2000;31:587–591
  4. Valla DC, Condat B. Portal vein thrombosis in adults: pathophysiology, pathogenesis and management. J Hepatol. 2000;32:865–871
  5. Janssen HL, Wijnhoud A, Haagsma EB, et al. Extrahepatic portal vein thrombosis: aetiology and determinants of survival. Gut. 2001;49:720–724
  6. Sarin SK, Agarwal SR. Extrahepatic portal vein obstruction. Semin Liver Dis. 2002;22:43–58
  7. Sobhonslidsuk A, Reddy KR. Portal vein thrombosis: a concise review. Am J Gastroenterol. 2002;97:535–541
  8. Harmanci O, Bayraktar Y. Portal hypertension due to portal venous thrombosis: etiology and clinical outcome. World J Gastroenterol. 2007;13:2535–2540
  9. Condat B, Valla D. Nonmalignant portal vein thrombosis in adults. Nat Clin Pract Gastroenterol Hepatol. 2006;3:505–515
  10. Amitrano L, Guardascione MA, Scaglione M, et al. Prognostic factors in noncirrhotic patients with splanchnic vein thromboses. Am J Gastroenterol. 2007;102:1–7
  11. Sanjal AJ, Freedman AM, Luketic VA, et al. Transjugular intrahepatic portosystemic shunts for patients with active variceal hemorrhage unresponsive to sclerotheraphy. Gastroenterology. 1996;111:138–146
  12. Rossle M, Deibert P, Haag K, et al. Randomised trial of transjugular-intrahepatic-portosystemic shunt versus endoscopy plus propanolol for prevention of variceal rebleeding. Lancet. 1997;349:1043–1049
  13. Merli M, Salerno F, Riggio O, et al. Transjugular intrahepatic portosystemic shunt versus endoscopic sclerotheraphy for the prevention of variceal bleeding in cirrhosis: a randomized multicenter trial. Hepatology. 1998;27:40–45
  14. Lebrec D, Giuily N, Hadengue A, et al. Transjugular intrahepatic portosystemic shunts: comparison with paracentesis in patient with cirrhosis and refractory ascites: a randomized trial. J Hepatol. 1996;25:135–144
  15. Rossle M, Ochs A, Gulberg V, et al. A comparison of paracentesis and transjugular intrahepatic portosystemic shunting in patients with ascites. N Engl J Med. 2000;342:1701–1707
  16. Gines P, Uriz J, Calahorra B, et al. Transjugular intrahepatic portosystemic shunt versus paracentesis plus albumin for refractory ascites in cirrhosis. Gastroenterology. 2002;123:1839–1847
  17. Sanyal AJ, Genning C, Reddy KR, et al. The North American study for the treatment of refractory ascites. Gastroenterology. 2003;124:634–641
  18. Salerno F, Merli M, Riggio O, et al. Randomized controlled study of TIPS versus paracentesis plus albumin in cirrhosis with severe ascites. Hepatology. 2004;40:629–635
  19. Sarin SK, Sollano JD, Chawla YK, et al. Consensus on extra-hepatic portal vein obstruction. Liver Int. 2006;26:512–519
  20. Radosevich PM, Ring EJ, LaBerge JM, et al. Transjugular intrahepatic portosystemic shunt in patients with portal vein occlusion. Radiology. 1993;186:523–527
  21. Walser EM, McNees SW, DeLa Pena O, et al. Portal venous thrombosis: percutaneous therapy and outcome. J Vasc Interv Radiol. 1998;9:119–127
  22. Jiang ZB, Shan H, Shen XY, et al. Transjugular intrahepatic portosystemic shunt for palliative treatment of portal hypertension secondary to portal vein tumor thrombosis. World J Gastroenterol. 2004;10:1881–1884
  23. Kawamata H, Kumazaki T, Kanazawa H, et al. Transjugular intrahepatic portosystemic shunt in a patient with cavernomatous portal vein occlusion. Cardiovasc Intervent Radiol. 2000;23:145–149
  24. Van Ha TG, Hodge J, Funaky B, et al. Transjugular intrahepatic portosystemic shunt placement in patients with cirrhosis and concomitant portal vein thrombosis. Cardiovasc Intervent Radiol. 2006;29:785–790
  25. Bauer J, Johnson S, Durham J, et al. The role of TIPS for portal vein patency in liver transplant patients with portal vein thrombosis. Liver Transpl. 2006;12:1544–1551
  26. Senzolo M, Tibbals J, Cholongitas E, et al. Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with and without cavernous transformation. Aliment Pharmacol Ther. 2006;23:767–775
  27. Perarnau JM, Baju A, D’Alteroche L, et al. Feasibility and long-term evolution of TIPS in cirrhotic patients with portal thrombosis. Eur J Gastroenterol Hepatol. 2010;[Epub ahead of print]
  28. Bureau C, Garcia-Pagan JC, Layrargues GP, et al. Patency of stents covered with polytetrafluoroethylene in patients treated by transjugular intrahepatic portosystemic shunts: long-term results of a randomized multicentre study. Liver Int. 2007;27:742–747
  29. Angeloni S, Merli M, Salvatori F, et al. Polytetrafluorethylene-covered stent-graft for TIPS procedure: 1-year patency and clinical results. Am J Gastroenterol. 2004;99:280–285
  30. Rossi P, Salvatori FM, Fanelli F, et al. Polytetrafluoroethylene-covered nitinol stent-graft for transjugular intrahepatic portosystemic shunt creation: 3-year experience. Radiology. 2004;231:820–830
  31. Riggio O, Angeloni S, Salvatori FM, et al. Incidence, natural history and risk factors of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt with polytetrafluoroethylene-covered stent grafts. Am J Gastroenterol. 2008;103:1–9
  32. Wils A, van der Linden E, van Hoek B, et al. Transjugular intrahepatic portosystemic shunt in patients with chronic portal vein occlusion and cavernous transformation. J Clin Gastroenterol. 2009;10:982–984
  33. Semiz-Oysu A, Keussen I, Cwikiel W. Interventional radiological management of prehepatic obstruction the splanchnic venous system. Cardiovasc Intervent Radiol. 2007;30:688–695
  34. Bilbao JI, Elorz M, Vivas I, et al. Transjugular intrahepatic portosystemic shunt (TIPS) in the treatment of venous symptomatic chronic portal thrombosis in non-cirrhotic patients. Cardiovasc Intervent Radiol. 2004;27:474–480
  35. de Franchis R. Evolving consensus in portal hypertension. Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol. 2005;43:167–176
  36. Condat B, Pessione F, Hillaire S, et al. Current outcome of portal vein thrombosis in adults: risk and benefit of anticoagulant therapy. Gastroenterology. 2001;120:490–497
  37. Senzolo M, Patch D, Miotto D, et al. Interventional treatment should be incorporated in the algorithm for the management of patients with portal vein thrombosis. Hepatology. 2008;48:1352–1353
  38. Minguez B, Garcia-Pagan JC, Bosch J, et al. Non-cirrhotic portal vein thrombosis exhibits neuropsychological and MR changes consistent with minimal hepatic encephalopathy. Hepatology. 2006;43:707–714
  39. Senzolo M, Cholongitas E, Jibballs J, et al. Relief of biliary obstruction due to portal vein cavernoma using a transjugular intrahepatic portosystemic shunt (TIPS) without the need for long-term stenting. Endoscopy. 2006;38:760

PII: S1590-8658(10)00206-9

doi: 10.1016/j.dld.2010.06.001

Digestive and Liver Disease
Volume 43, Issue 1 , Pages 78-84 , January 2011

Article Tools

* Image Usage & Resolution